logo
Kids may get wrong ADHD diagnosis based on 'arbitrary thresholds', experts warn

Kids may get wrong ADHD diagnosis based on 'arbitrary thresholds', experts warn

Daily Mirror2 days ago

Many people are still living with ADHD without a diagnosis or support but an NHS-funded review suggests the real numbers with the condition is not on the rise
Diagnosing children with ADHD is based on 'arbitrary thresholds' which could cause the NHS to wrongly prescribe children drugs for the condition, experts warn.
Around three million Brits are thought to have Attention-Deficit/Hyperactivity Disorder and despite heightened awareness of the condition many remain undiagnosed. But an NHS-funded review has found 'evolving diagnosis criteria' may be in part why more people are being diagnosed but could find no evidence of a real increase in people with the condition since 2020. Leading experts insist the NHS is still playing 'catch up' after generations when there was no recognition of ADHD and many girls in particular remain undiagnosed.


Study author Dr Alex Martin, of King's College London, said: 'While assessments and help-seeking may be increasing, our study has shown significant gaps in the tracking of ADHD prevalence, resulting in a frustratingly unclear picture. The best data we have suggests that there has been no meaningful increase in ADHD prevalence.'
ADHD is characterised by difficulty focusing on things, hyperactivity and impulsivity. A previous study on seven million Brits showed there had been a 20-fold increase in people receiving a diagnosis for ADHD between 2000 and 2018. Among men aged 18 to 29 there was a 50-fold increase.
But experts warn clinicians may feel pressured to make 'artificial decisions' as changing cultural norms drive increased demand for children struggling at school to be diagnosed and get support. They warn about the risk of children wrongly being given ADHD drugs and say clinicians should be able to 'undiagnose' them if they improve.
Prof Phillip Shaw, director at the Institute of Psychiatry, Psychology and Neuroscience at King's College London, said: 'Giving medications for ADHD to people who don't have it - that's never a good idea. They are generally very safe medications… but they do have side effects and they have to be monitored.'
Jamie Oliver bravely reveals kids' health diagnosis as he opens up about 'bonkers' family
The NHS is pulling together better national data on ADHD which can significantly interfere with daily life and development. The neurodevelopmental condition can affect things like schoolwork, daily tasks and social interactions. The new paper by King's College London is the first systematic review of ADHD prevalence to be published since the start of the Covid-19 pandemic and looked at 40 studies.

Prof Edmund Sonuga-Barke, of King's College London, said: 'The history of ADHD in the UK is one of chronic under recognition so the increase in diagnoses we've seen over the last ten or so years is really a resetting or a catch up. And there's actually plenty more to do in this regard.'
However Prof Sonuga-Barke said diagnosis uses 'essentially arbitrary ADHD thresholds' that are 'not based on any natural, biological or clinical boundary'. He added: 'This forces us to consider how those thresholds are socially determined and culturally dependent. The fluidity around boundaries between ADHD and not ADHD inevitably leave clinicians having to make rather artificial decisions about very fine margins.'

Prof Phillip Shaw, who is one of the country's leading experts but was not involved in the research, said: 'For kids who are in the grey area there are three options here; to make a diagnosis or not, or often we just wait and watch. And for those kids in particular we always start educating the family and the child about what ADHD is and seeing if there are strategies they can use at home to help them. We also place an enormous emphasis on accommodations at school for the hyperactive kid [such as]... let them do their work standing up, maybe have preferential seating for inattentive kids, do things to break it [the work] up. You'll find all really good teachers already do this.'
People with the neuro-developmental disorder may have trouble concentrating or sitting still, while other symptoms include being easily distracted, forgetfulness, finding it hard to follow instructions or organise time, and making impulsive decisions. Best estimates from a 2018 study suggests true prevalence of ADHD among children could be 5%. Back then 2.5% of boys and 0.7% of girls in the UK had been diagnosed but this is likely to have increased since then. An estimated 2-3% of adults had ADHD but only around 1% had a diagnosis.
Prof Phillip Shaw warned children with other mental health problems such as anxiety could be mistakenly labelled as having ADHD. He added: 'My hunch is that there's such a huge awareness of ADHD that it's often used as a language of distress. It's sometimes used to express that children and young people are struggling, particularly at school, and need help. And of course, when a child is having problems that are impacting their life in a sustained way, they deserve a full mental health assessment, even if the final diagnosis doesn't end up being ADHD.'

Researchers admitted all but four of the studies included in the review were 'poor quality' and more research is needed. However surveys included did suggest there has been 'no significant rise' in the number of people who actually have the condition since 2020. Social media platforms like TikTok have played a role in raising awareness.
Earlier this month NHS England estimated for the first time that 2,498,000 people in England may have ADHD, which includes those without a diagnosis. An estimated 741,000 are children and young people aged five to 24. More than half a million people (549,000) were waiting for an ADHD assessment at the end of March 2025, up from 416,000 a year earlier.
Catherine Hinwood, NHS England's ADHD Programme Director said: 'This research backs the long-term vision set out in our recently published ADHD data improvement plan to have accurate national data on all aspects of ADHD – and we published our first ever national ADHD data set including estimated prevalence figures last week. Patients are waiting too long for an ADHD assessment and diagnosis and that's why the NHS has also launched an independent taskforce to investigate the challenges facing services and help them manage the rising numbers of referrals, with support from across society.'
This study was funded by NHS England and was conducted by the NIHR Health Protection Research Unit in Emergency Preparedness and Response. It is published in the Journal of Affective Disorders.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Covid booster warning as Covid NB.1.8.1 cases on the rise
Covid booster warning as Covid NB.1.8.1 cases on the rise

Rhyl Journal

time34 minutes ago

  • Rhyl Journal

Covid booster warning as Covid NB.1.8.1 cases on the rise

The message comes after health experts also warned of a new COVID-19 variant, with cases of the strain are on the rise around the world. Covid NB.1.8.1 is a variation of the XDV.1.5.1 strain and was first detected back in January 2025. Ifti Khan, superintendent pharmacist at Well Pharmacy, urged those eligible to book as soon as possible and get the booster while it is still available. He said: 'Covid will most likely rise coming into the end of spring and into summer as people mix with friends and family more often. 'We know from previous boosters that they are effective in making sure that patients' symptoms are not as severe as they might have been without so I would urge patients to pop into their local Well Pharmacy store and get their jab. 'Patients have just over two weeks as the spring booster programme ends on June 17 so it would be my hope that those who can get a jab, opt to do so before enjoying socialising during summer.' Mr Khan warned that at this time of year, some people may believe they have hay fever as early symptoms of Covid include a runny or blocked nose or a sore throat. Covid tests can be obtained at any Well Pharmacy. The WHO has placed the Covid NB.1.8.1 "under monitoring" due to the rise in cases worldwide. It is one of six COVID-19 variants currently being monitored. The new 'Strategic and operational plan for coronavirus disease threat management: at a glance' sets out the global framework for supporting Member States in the sustained, integrated, evidence-based management of coronavirus disease threats, including #COVID19, MERS, and… However, the WHO stated that the risk posed by the new variant was "low," and that approved COVID-19 vaccines are expected to be effective against it. The world health experts, in a recent risk evaluation, said: "Despite a concurrent increase in cases and hospitalisations in some countries where NB.1.8.1 is widespread, current data do not indicate that this variant leads to more severe illness than other variants in circulation. The WHO added: "The available evidence on NB.1.8.1 does not suggest additional public health risks relative to the other currently circulating Omicron descendent lineages." COVID NB.1.8.1 has already been detected in 22 countries. These include the likes of Australia, China, Hong Kong, Thailand and the US, according to The Independent. The coming COVID-19 Winter Surge in Australia will show the world where we are actually headed is happening in South-Eats Asia and East Asia are just the 'preludes'...watch how NB.1.8.1 spawns are evolving including PQ.1, PQ.2 and even sub-lineages like PE.1. Cases of the NB.1.8.1 variant have also been confirmed in Northern Ireland, Wales, and "popular British tourist hotspots", the news outlet added.

Covid booster warning as Covid NB.1.8.1 cases on the rise
Covid booster warning as Covid NB.1.8.1 cases on the rise

South Wales Argus

time34 minutes ago

  • South Wales Argus

Covid booster warning as Covid NB.1.8.1 cases on the rise

The message comes after health experts also warned of a new COVID-19 variant, with cases of the strain are on the rise around the world. Covid NB.1.8.1 is a variation of the XDV.1.5.1 strain and was first detected back in January 2025. Ifti Khan, superintendent pharmacist at Well Pharmacy, urged those eligible to book as soon as possible and get the booster while it is still available. He said: 'Covid will most likely rise coming into the end of spring and into summer as people mix with friends and family more often. 'We know from previous boosters that they are effective in making sure that patients' symptoms are not as severe as they might have been without so I would urge patients to pop into their local Well Pharmacy store and get their jab. 'Patients have just over two weeks as the spring booster programme ends on June 17 so it would be my hope that those who can get a jab, opt to do so before enjoying socialising during summer.' Mr Khan warned that at this time of year, some people may believe they have hay fever as early symptoms of Covid include a runny or blocked nose or a sore throat. Covid tests can be obtained at any Well Pharmacy. World Health Organisation monitoring COVID NB.1.8.1 The WHO has placed the Covid NB.1.8.1 "under monitoring" due to the rise in cases worldwide. It is one of six COVID-19 variants currently being monitored. The new 'Strategic and operational plan for coronavirus disease threat management: at a glance' sets out the global framework for supporting Member States in the sustained, integrated, evidence-based management of coronavirus disease threats, including #COVID19, MERS, and… — World Health Organization (WHO) (@WHO) May 28, 2025 However, the WHO stated that the risk posed by the new variant was "low," and that approved COVID-19 vaccines are expected to be effective against it. The world health experts, in a recent risk evaluation, said: "Despite a concurrent increase in cases and hospitalisations in some countries where NB.1.8.1 is widespread, current data do not indicate that this variant leads to more severe illness than other variants in circulation. The WHO added: "The available evidence on NB.1.8.1 does not suggest additional public health risks relative to the other currently circulating Omicron descendent lineages." Where has Covid NB.1.8.1 been detected? COVID NB.1.8.1 has already been detected in 22 countries. These include the likes of Australia, China, Hong Kong, Thailand and the US, according to The Independent. The coming COVID-19 Winter Surge in Australia will show the world where we are actually headed is happening in South-Eats Asia and East Asia are just the 'preludes'...watch how NB.1.8.1 spawns are evolving including PQ.1, PQ.2 and even sub-lineages like PE.1. — Thailand Medical News (@ThailandMedicaX) June 4, 2025 COVID NB.1.8.1 in the UK Cases of the NB.1.8.1 variant have also been confirmed in Northern Ireland, Wales, and "popular British tourist hotspots", the news outlet added.

Symptoms of 'different' Nimbus virus as UKHSA confirms it has reached UK
Symptoms of 'different' Nimbus virus as UKHSA confirms it has reached UK

Daily Mirror

time44 minutes ago

  • Daily Mirror

Symptoms of 'different' Nimbus virus as UKHSA confirms it has reached UK

Doctors say the virus appears to be able to spread easily and has already been detected in 22 countries For many of us, Covid-19 feels like a chapter we've closed – along with the days of PCR tests, mask mandates and daily case updates. But while life may feel back to normal, the virus hasn't completely vanished. In fact, new variants continue to quietly circulate. One of the latest to appear on the radar is NB.1.8.1 – a name that you may have seen pop up in headlines and on social media feeds this week. This newly emerging sub-variant hasn't triggered widespread concern, but it has caught the attention of scientists and health officials. ‌ The UK Health Security Agency (UKHSA) announced this week that NB.1.8.1 has so far only been detected in small numbers within the UK, but added that international data indicates that the sub-variant is steadily accounting for a growing share of global Covid-19 cases. ‌ We consulted some GPs to find out exactly what sets the NB.1.8.1 Covid variant apart from the rest. Is it more contagious, more immune-evasive, or simply another step in Covid's slow evolution? Here's what they know so far… What is the new NB.1.8.1 Covid variant and where has it come from? 'The NB.1.8.1 variant, also referred to as Nimbus, is a new strain of the Covid-19 virus that has emerged due to mutations in its genetic material,' says Dr Naveed Asif, GP at The London General Practice. It's a sub-variant of Omicron, says Dr Chun Tang, GP at Pall Mall Medical. 'Variants like this pop up when the virus mutates, which is normal for viruses, especially ones that spread widely,' explains Tang. 'NB.1.8.1 was first picked up in early 2025 and has since been detected in several countries, including the UK, China and US. It's got some new mutations that scientists are keeping a close eye on.' How is Nimbus different from previous variants? 'NB.1.8.1 isn't too different from the Omicron variant, but it does have some tweaks to its spike protein, which might make it spread a bit more easily or slip past some of our existing immunity,' says Tang. 'That said, early signs suggest it doesn't seem to cause more serious illness, but of course, we're still learning more about it.' ‌ However, Nimbus does appear to be more transmissible than previous variants, with notable increases reported in India, Hong Kong, Singapore, and Thailand, notes Asif. 'Its spread has been identified in around 22 countries,' says Asif. 'The World Health Organization (WHO) assesses the additional risk to the global public as currently low, and existing Covid-19 vaccines are considered effective in preventing severe disease.' ‌ How is Nimbus spreading? 'It's spreading in the usual way, person to person, mainly through respiratory droplets when people cough, sneeze or even just talk closely,' says Tang. 'Like other variants, it can hang around in the air in poorly ventilated spaces.' What Nimbus Covid symptoms should people look out for? 'Common symptoms of the NB.1.8.1 variant include severe sore throat (described as a 'razor blade sensation'), fatigue, mild cough, fever, muscle aches and congestion,' says Asif. 'However, symptoms can vary widely so vigilance is key.' What are the Nimbus treatment options? 'Treatment for Nimbus generally aligns with that for other Covid-19 variants,' says Asif. 'Most individuals will recover at home with rest, hydration, and over-the-counter medications for symptom management. ‌ 'For those with severe symptoms or high-risk complications, antiviral medications or monoclonal antibody treatments may be recommended. Always consult your GP for personalised advice.' How can you avoid getting the Nimbus variant? 'Make sure everyone's up to date with their Covid-19 jabs, especially boosters,' recommends Tang. 'Wash your hands regularly, keep rooms well ventilated, and consider popping a mask on in busy places or if you're around people who are more vulnerable. 'If someone in the house is feeling poorly, try to keep some distance and clean shared surfaces regularly.' When should you see a GP about Covid? 'Seek medical advice if you experience Covid-19 symptoms, especially if they worsen or if you have underlying health conditions that increase your risk,' advises Asif. 'Additionally, consult your GP if you've been in close contact with someone who has tested positive for the NB.1.8.1 variant or if you have health concerns.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store